Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call

Replay

Replay transcript excerpt

Good day, and welcome to the Bionano first quarter 2025 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from Investor Relations. Please go ahead. Thank you, Lisa, and good afternoon, everyone. Welcome to Bionano first quarter 2025 financial results conference call. Leading the call today is Dr. Eric Holman, CEO and Principal Financial Officer of Bionano. and he is joined by Mark Adamczyk, Bionano's Vice President of Accounting and Principal Accounting Officer. After market closed today, Bionano issued a press release accounting its financial results for the first quarter 2025. A copy of the release can be found on the investor relations page of the company's website. Certain statements made during this conference call may be forward-looking statements. including statements about BioNano's revenue outlook, profitability, cash runway, cost savings initiatives, and commercialization and product plans. Such statements are based on current expectations, and there can be no assurances that the results contemplated in these statements will be realized. Actual results may differ materially from such statements due to several factors and risks. some of which are identified in BioNano's press release and BioNano's reports filed with the SEC. These forward-looking statements are based on information available to BioNano today, May 14, 2025, and the company assumes no obligation to update statements as circumstances change. In addition, to supplement BioNano's financial results in accordance with the U.S. generally accepted accounting principles, or GAAP, The company reports certain non-GAAP financial measures. A description of these non-GAAP financial measures, as well as reconciliation to th...